Based on the results of a recent PPMD-funded study, Eli Lilly has begun a Phase III study to determine if tadalafil, a drug typically prescribed for erectile dysfunction or increased pressure in the arteries, can slow the progression of #Duchenne (more information about participating in the study is included below). If tadalafil proves successful in slowing the progression of the disease it may be a good candidate to combine with other types of therapy that are mutation-specific or target other consequences of the loss of dystrophin in muscle cells.
Posted on: Wed, 07 May 2014 20:20:35 +0000
Trending Topics
Recently Viewed Topics
© 2015